| C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of and affects the localization of KEAP1 protein" | 27178040 |
| C050642 | 1,2-dihydroxynaphthalene | "1,2-dihydroxynaphthalene analog results in increased metabolism of KEAP1 protein" | 25807370 |
| C050642 | 1,2-dihydroxynaphthalene | "Glutathione inhibits the reaction [1,2-dihydroxynaphthalene analog results in increased metabolism of KEAP1 protein]" | 25807370 |
| C049325 | 1,2-dithiol-3-thione | "1,2-dithiol-3-thione inhibits the reaction [KEAP1 protein binds to NFE2L2 protein]" | 15302862 |
| C118009 | 1,2-epoxy-4-vinylcyclohexane | "1,2-epoxy-4-vinylcyclohexane results in decreased expression of KEAP1 mRNA" | 26117601 |
| C040756 | 1,2-naphthoquinone | "1,2-naphthoquinone results in increased metabolism of KEAP1 protein" | 21384861|2580737 |
| C040756 | 1,2-naphthoquinone | "KEAP1 protein affects the susceptibility to 1,2-naphthoquinone" | 21384861 |
| C576882 | 1-(2-trifluoromethoxyphenyl)-2-nitroethanone | 1-(2-trifluoromethoxyphenyl)-2-nitroethanone results in increased expression of KEAP1 mRNA | 25596134 |
| C477819 | 15-deoxyprostaglandin J2 | 15-deoxyprostaglandin J2 affects the metabolism of KEAP1 protein | 18785192 |
| C016403 | 2,4-dinitrotoluene | "2,4-dinitrotoluene affects the expression of KEAP1 mRNA" | 21346803 |
| C022960 | 2-oxindole | 2-oxindole inhibits the reaction [CUL3 protein binds to KEAP1 protein] | 22245129 |
| C022960 | 2-oxindole | 2-oxindole results in decreased activity of KEAP1 protein | 22245129 |
| C022960 | 2-oxindole | [2-oxindole results in decreased activity of KEAP1 protein] which results in decreased ubiquitination of NFE2L2 protein | 22245129 |
| C552929 | 2-(pro-1-ynyl)-5-(5,6-dihydroxypenta-1,3-diynyl)thiophene | "2-(pro-1-ynyl)-5-(5,6-dihydroxypenta-1,3-diynyl)thiophene results in increased glutathionylation of KEAP1 protein" | 20800667 |
| C552929 | 2-(pro-1-ynyl)-5-(5,6-dihydroxypenta-1,3-diynyl)thiophene | "Glutathione inhibits the reaction [2-(pro-1-ynyl)-5-(5,6-dihydroxypenta-1,3-diynyl)thiophene results in increased glutathionylation of KEAP1 protein]" | 20800667 |
| C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone inhibits the reaction [KEAP1 protein binds to CUL3 protein] | 18417180 |
| C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone inhibits the reaction [KEAP1 protein results in increased ubiquitination of NFE2L2 protein] | 18417180 |
| C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone promotes the reaction [KEAP1 protein binds to NFE2L2 protein] | 18417180 |
| C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone results in increased expression of KEAP1 protein | 19033392 |
| C018855 | 2-tert-butylhydroquinone | KEAP1 protein mutant form inhibits the reaction [2-tert-butylhydroquinone results in increased expression of and results in increased activity of NFE2L2 protein] | 23589329 |
| C018855 | 2-tert-butylhydroquinone | KEAP1 protein mutant form results in decreased susceptibility to 2-tert-butylhydroquinone | 23589329 |
| C018855 | 2-tert-butylhydroquinone | KEAP1 protein promotes the reaction [2-tert-butylhydroquinone results in increased expression of and results in increased activity of NFE2L2 protein] | 23589329 |
| C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone binds to KEAP1 protein | 19808700 |
| C018855 | 2-tert-butylhydroquinone | [2-tert-butylhydroquinone co-treated with benzyloxycarbonylleucyl-leucyl-leucine aldehyde] promotes the reaction [NFE2L2 protein binds to KEAP1 protein] | 18512965 |
| C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone promotes the reaction [NFE2L2 protein binds to KEAP1 protein] | 18512965 |
| C018855 | 2-tert-butylhydroquinone | Cadmium Chloride inhibits the reaction [2-tert-butylhydroquinone promotes the reaction [NFE2L2 protein binds to KEAP1 protein]] | 18512965 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "3,4,5,3',4'-pentachlorobiphenyl promotes the reaction [CAV1 mutant form results in decreased expression of KEAP1 protein]" | 24709675 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of KEAP1 protein" | 24709675 |
| C093027 | 3-butylidene-4,5,6,7-tetrahydro-6,7-dihydroxy-1(3H)-isobenzofuranone | "KEAP1 protein inhibits the reaction [3-butylidene-4,5,6,7-tetrahydro-6,7-dihydroxy-1(3H)-isobenzofuranone affects the localization of HMOX1 protein]" | 19961840 |
| C093027 | 3-butylidene-4,5,6,7-tetrahydro-6,7-dihydroxy-1(3H)-isobenzofuranone | "KEAP1 protein inhibits the reaction [3-butylidene-4,5,6,7-tetrahydro-6,7-dihydroxy-1(3H)-isobenzofuranone affects the localization of NFE2L2 protein]" | 19961840 |
| C527796 | 3-morpholinopropyl isothiocyanate | 3-morpholinopropyl isothiocyanate results in decreased expression of KEAP1 protein | 20498004 |
| C028398 | 4-(2-pyridylazo)resorcinol | 4-(2-pyridylazo)resorcinol inhibits the reaction [Zinc binds to KEAP1 protein] | 15865434 |
| C028398 | 4-(2-pyridylazo)resorcinol | "4,4'-dipyridyl disulfide promotes the reaction [4-(2-pyridylazo)resorcinol inhibits the reaction [Zinc binds to KEAP1 protein]]" | 15865434 |
| C028398 | 4-(2-pyridylazo)resorcinol | Hydrogen Peroxide promotes the reaction [4-(2-pyridylazo)resorcinol inhibits the reaction [Zinc binds to KEAP1 protein]] | 15865434 |
| C028398 | 4-(2-pyridylazo)resorcinol | sulforafan promotes the reaction [4-(2-pyridylazo)resorcinol inhibits the reaction [Zinc binds to KEAP1 protein]] | 15865434 |
| C009505 | 4,4'-diaminodiphenylmethane | "4,4'-diaminodiphenylmethane results in decreased expression of KEAP1 mRNA" | 18648102 |
| C007542 | 4,4'-dipyridyl disulfide | "4,4'-dipyridyl disulfide inhibits the reaction [5,5'-bis(8-(phenylamino)-1-naphthalenesulfonate) binds to KEAP1 protein]" | 15865434 |
| C007542 | 4,4'-dipyridyl disulfide | "4,4'-dipyridyl disulfide promotes the reaction [4-(2-pyridylazo)resorcinol inhibits the reaction [Zinc binds to KEAP1 protein]]" | 15865434 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KEAP1 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KEAP1 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KEAP1 mRNA" | 27188386 |
| C035207 | 4-amino-2,6-dinitrotoluene | "4-amino-2,6-dinitrotoluene affects the expression of KEAP1 mRNA" | 21346803 |
| C012606 | 4-vinyl-1-cyclohexene dioxide | 4-vinyl-1-cyclohexene dioxide results in increased expression of KEAP1 mRNA | 26117601 |
| C013733 | 4-vinylcyclohexene | 4-vinylcyclohexene results in increased expression of KEAP1 mRNA | 24681254 |
| C035763 | 5,5'-bis(8-(phenylamino)-1-naphthalenesulfonate) | "4,4'-dipyridyl disulfide inhibits the reaction [5,5'-bis(8-(phenylamino)-1-naphthalenesulfonate) binds to KEAP1 protein]" | 15865434 |
| C035763 | 5,5'-bis(8-(phenylamino)-1-naphthalenesulfonate) | "5,5'-bis(8-(phenylamino)-1-naphthalenesulfonate) binds to KEAP1 protein" | 15865434 |
| C522589 | 5,6-dihydrocyclopenta-1,2-dithiole-3-thione | "5,6-dihydrocyclopenta-1,2-dithiole-3-thione promotes the reaction [NFE2L2 protein binds to KEAP1 protein]" | 22558124 |
| C522589 | 5,6-dihydrocyclopenta-1,2-dithiole-3-thione | "KEAP1 protein results in increased susceptibility to 5,6-dihydrocyclopenta-1,2-dithiole-3-thione" | 22558124 |
| C522589 | 5,6-dihydrocyclopenta-1,2-dithiole-3-thione | "5,6-dihydrocyclopenta-1,2-dithiole-3-thione promotes the reaction [NFE2L2 protein binds to KEAP1 protein]" | 22558124 |
| C522589 | 5,6-dihydrocyclopenta-1,2-dithiole-3-thione | "KEAP1 protein results in increased susceptibility to 5,6-dihydrocyclopenta-1,2-dithiole-3-thione" | 22558124 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KEAP1 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KEAP1 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KEAP1 mRNA" | 27188386 |
| C579811 | 7-O-galloyltaxifolin | 7-O-galloyltaxifolin results in decreased expression of KEAP1 | 23294286 |
| D000082 | Acetaminophen | Acetaminophen results in decreased expression of KEAP1 mRNA | 21420995 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of KEAP1 mRNA | 25881548 |
| D000082 | Acetaminophen | ABCC3 protein affects the reaction [KEAP1 protein affects the glucuronidation of Acetaminophen] | 19246624 |
| D000082 | Acetaminophen | KEAP1 gene mutant form results in decreased susceptibility to Acetaminophen | 16293230|2549971 |
| D000082 | Acetaminophen | KEAP1 protein affects the glucuronidation of Acetaminophen | 19246624 |
| D000082 | Acetaminophen | KEAP1 protein affects the glutathionylation of Acetaminophen | 19246624 |
| D000082 | Acetaminophen | KEAP1 protein affects the sulfation of Acetaminophen | 19246624 |
| D000082 | Acetaminophen | KEAP1 results in increased susceptibility to Acetaminophen | 20404090 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Dinitrochlorobenzene results in increased expression of KEAP1 protein] | 19033392 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Indomethacin inhibits the reaction [KEAP1 protein binds to NFE2L2 protein]] | 11909699 |
| D000171 | Acrolein | Buthionine Sulfoximine inhibits the reaction [[KEAP1 gene mutant form results in increased activity of NFE2L2] which results in decreased susceptibility to Acrolein] | 19608619 |
| D000171 | Acrolein | [KEAP1 gene mutant form results in increased activity of NFE2L2] which results in decreased susceptibility to Acrolein | 19608619 |
| D000393 | Air Pollutants | Air Pollutants results in decreased expression of KEAP1 mRNA | 28389379 |
| D000393 | Air Pollutants | Air Pollutants results in decreased expression of KEAP1 protein | 28389379 |
| C050234 | altertoxin II | altertoxin II results in increased expression of and affects the localization of KEAP1 protein | 27178040 |
| D006710 | Homocysteine | Homocysteine results in increased expression of KEAP1 protein | 22964297 |
| D000638 | Amiodarone | Amiodarone results in decreased expression of KEAP1 mRNA | 17991464 |
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of KEAP1 mRNA | 16483693 |
| C000228 | aristolochic acid I | aristolochic acid I results in increased expression of KEAP1 protein | 24530882 |
| C000228 | aristolochic acid I | "methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate inhibits the reaction [aristolochic acid I results in increased expression of KEAP1 protein]" | 24530882 |
| D001151 | Arsenic | Arsenic results in decreased expression of KEAP1 protein | 26385919 |
| D001151 | Arsenic | Arsenic results in increased expression of KEAP1 mRNA | 14567983 |
| D001151 | Arsenic | Arsenic results in increased expression of KEAP1 protein | 14567983 |
| D001151 | Arsenic | Arsenic binds to KEAP1 protein | 19808700 |
| D001151 | Arsenic | KEAP1 protein affects the susceptibility to Arsenic | 19808700 |
| C006632 | arsenic trioxide | arsenic trioxide affects the reaction [KEAP1 protein results in increased expression of CCND1 protein] | 22684020 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of KEAP1 mRNA | 15894607|1941714 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of KEAP1 protein | 22684020 |
| C006632 | arsenic trioxide | KEAP1 mRNA inhibits the reaction [Ethionamide results in increased susceptibility to arsenic trioxide] | 26708503 |
| C006632 | arsenic trioxide | KEAP1 mRNA results in increased susceptibility to arsenic trioxide | 26708503 |
| C006632 | arsenic trioxide | KEAP1 protein inhibits the reaction [arsenic trioxide results in decreased expression of CCND1 mRNA] | 22684020 |
| C006632 | arsenic trioxide | KEAP1 protein inhibits the reaction [arsenic trioxide results in increased expression of PPARG mRNA] | 22684020 |
| C006632 | arsenic trioxide | KEAP1 protein inhibits the reaction [arsenic trioxide results in increased expression of PPARG protein] | 22684020 |
| C006632 | arsenic trioxide | KEAP1 protein promotes the reaction [rosiglitazone results in increased susceptibility to arsenic trioxide] | 22684020 |
| C006632 | arsenic trioxide | KEAP1 protein promotes the reaction [troglitazone results in increased susceptibility to arsenic trioxide] | 22684020 |
| C006632 | arsenic trioxide | KEAP1 protein results in decreased susceptibility to arsenic trioxide | 22684020 |
| C006632 | arsenic trioxide | NFE2L2 protein promotes the reaction [arsenic trioxide results in increased expression of KEAP1 protein] | 22684020 |
| C006632 | arsenic trioxide | [Tretinoin co-treated with arsenic trioxide] results in increased expression of KEAP1 mRNA | 15894607 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of KEAP1 protein | 24634002 |
| C015001 | arsenite | arsenite results in decreased expression of KEAP1 mRNA | 22476201 |
| C015001 | arsenite | arsenite results in decreased expression of KEAP1 protein | 22476201 |
| C015001 | arsenite | arsenite results in increased expression of KEAP1 mRNA | 22476201 |
| C015001 | arsenite | arsenite results in increased expression of KEAP1 protein | 22476201 |
| C015001 | arsenite | KEAP1 protein affects the reaction [arsenite results in decreased expression of NFE2L1 mRNA] | 22476201 |
| C015001 | arsenite | KEAP1 protein affects the reaction [arsenite results in increased expression of GCLC mRNA] | 22476201 |
| C015001 | arsenite | KEAP1 protein affects the reaction [arsenite results in increased expression of GCLC protein] | 22476201 |
| C015001 | arsenite | KEAP1 protein affects the reaction [arsenite results in increased expression of GCLM mRNA] | 22476201 |
| C015001 | arsenite | KEAP1 protein affects the reaction [arsenite results in increased expression of HMOX1 mRNA] | 22476201 |
| C015001 | arsenite | KEAP1 protein affects the reaction [arsenite results in increased expression of NFE2L1 protein] | 22476201 |
| C015001 | arsenite | KEAP1 protein affects the reaction [arsenite results in increased expression of NFE2L2 mRNA] | 22476201 |
| C015001 | arsenite | KEAP1 protein affects the reaction [arsenite results in increased expression of NFE2L2 protein] | 22476201 |
| C015001 | arsenite | KEAP1 protein affects the reaction [arsenite results in increased expression of NQO1 mRNA] | 22476201 |
| C015001 | arsenite | KEAP1 protein affects the reaction [arsenite results in increased expression of SRXN1 mRNA] | 22476201 |
| C015001 | arsenite | KEAP1 protein affects the susceptibility to arsenite | 22476201 |
| C015001 | arsenite | NFE2L2 protein inhibits the reaction [arsenite results in increased expression of KEAP1 mRNA] | 22476201 |
| C015001 | arsenite | NFE2L2 protein inhibits the reaction [arsenite results in increased expression of KEAP1 protein] | 22476201 |
| C015001 | arsenite | NFE2L2 protein promotes the reaction [arsenite results in decreased expression of KEAP1 mRNA] | 22476201 |
| C015001 | arsenite | NFE2L2 protein promotes the reaction [arsenite results in decreased expression of KEAP1 protein] | 22476201 |
| D001280 | Atrazine | Atrazine results in decreased expression of KEAP1 mRNA | 22378314 |
| D001379 | Azathioprine | KEAP1 protein affects the susceptibility to Azathioprine | 21803983 |
| C487081 | belinostat | belinostat results in decreased expression of KEAP1 mRNA | 19606018 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of KEAP1 mRNA | 20498004|2594648 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of KEAP1 protein | 20498004 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of KEAP1 mRNA | 20106945|2125695 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of KEAP1 mRNA | 21569818|2222880 |
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | "7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of KEAP1 mRNA" | 19150397 |
| D016227 | Benzoquinones | Benzoquinones analog binds to and results in increased metabolism of KEAP1 protein | 21651925 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | [2-tert-butylhydroquinone co-treated with benzyloxycarbonylleucyl-leucyl-leucine aldehyde] promotes the reaction [NFE2L2 protein binds to KEAP1 protein] | 18512965 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [NFE2L2 protein binds to KEAP1 protein] | 18512965 |
| C034786 | bis(4-hydroxycinnamoyl)methane | KEAP1 protein inhibits the reaction [bis(4-hydroxycinnamoyl)methane results in increased expression of HMOX1 mRNA] | 17535857 |
| C017807 | bisbenzimide ethoxide trihydrochloride | KEAP1 protein results in decreased export of bisbenzimide ethoxide trihydrochloride | 25841332 |
| C006780 | bisphenol A | bisphenol A results in increased expression of KEAP1 mRNA | 23606268 |
| C006780 | bisphenol A | [nonylphenol co-treated with bisphenol A] results in increased expression of KEAP1 mRNA | 23606268 |
| C006780 | bisphenol A | bisphenol A affects the expression of KEAP1 mRNA | 25181051 |
| C006780 | bisphenol A | bisphenol A results in increased methylation of KEAP1 gene | 28505145 |
| C005961 | bis(tri-n-butyltin)oxide | bis(tri-n-butyltin)oxide affects the localization of KEAP1 protein | 21601586 |
| D001761 | Bleomycin | Bleomycin results in decreased expression of KEAP1 protein | 26768587 |
| D001761 | Bleomycin | tripterine inhibits the reaction [Bleomycin results in decreased expression of KEAP1 protein] | 26768587 |
| C020237 | brusatol | [KEAP1 protein results in decreased expression of NFE2L2 protein] which results in decreased susceptibility to brusatol | 21205897 |
| D019328 | Buthionine Sulfoximine | Buthionine Sulfoximine inhibits the reaction [[KEAP1 gene mutant form results in increased activity of NFE2L2] which results in decreased susceptibility to Acrolein] | 19608619 |
| D019328 | Buthionine Sulfoximine | Buthionine Sulfoximine inhibits the reaction [[KEAP1 gene mutant form results in increased activity of NFE2L2] which results in decreased susceptibility to Chlorambucil] | 19608619 |
| D019328 | Buthionine Sulfoximine | Buthionine Sulfoximine inhibits the reaction [[KEAP1 gene mutant form results in increased activity of NFE2L2] which results in decreased susceptibility to cumene hydroperoxide] | 19608619 |
| D019328 | Buthionine Sulfoximine | Buthionine Sulfoximine inhibits the reaction [[KEAP1 gene mutant form results in increased activity of NFE2L2] which results in increased abundance of Glutathione] | 19608619 |
| D020122 | tert-Butylhydroperoxide | Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased expression of KEAP1 protein] | 27050144 |
| D020122 | tert-Butylhydroperoxide | Quercetin inhibits the reaction [tert-Butylhydroperoxide results in increased expression of KEAP1 protein] | 27050144 |
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in increased expression of KEAP1 protein | 27050144 |
| D002104 | Cadmium | Cadmium results in increased degradation of KEAP1 protein | 27658547 |
| C028031 | cadmium acetate | cadmium acetate results in decreased expression of KEAP1 protein | 29140578 |
| C028031 | cadmium acetate | Trehalose inhibits the reaction [cadmium acetate results in decreased expression of KEAP1 protein] | 29140578 |
| D019256 | Cadmium Chloride | KEAP1 protein inhibits the reaction [Cadmium Chloride results in increased expression of MT1E mRNA] | 26827822 |
| D019256 | Cadmium Chloride | Cadmium Chloride affects the reaction [NFE2L2 protein binds to KEAP1 protein] | 18512965 |
| D019256 | Cadmium Chloride | [Cadmium Chloride affects the reaction [NFE2L2 protein binds to KEAP1 protein]] affects the localization of [NFE2L2 protein binds to KEAP1 protein] | 18512965 |
| D019256 | Cadmium Chloride | Cadmium Chloride binds to KEAP1 protein | 19808700|2682782 |
| D019256 | Cadmium Chloride | Cadmium Chloride inhibits the reaction [2-tert-butylhydroquinone promotes the reaction [NFE2L2 protein binds to KEAP1 protein]] | 18512965 |
| D019256 | Cadmium Chloride | Cadmium Chloride inhibits the reaction [KEAP1 gene mutant form results in increased expression of NFE2L2 protein] | 26827822 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in decreased expression of KEAP1 mRNA | 20061341 |
| D019256 | Cadmium Chloride | KEAP1 gene mutant form promotes the reaction [Cadmium Chloride results in increased expression of NFE2L2 protein] | 26827822 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of KEAP1 protein | 26462792 |
| D019256 | Cadmium Chloride | [Grape Seed Proanthocyanidins co-treated with Cadmium Chloride] affects the expression of KEAP1 mRNA | 25719599 |
| D019256 | Cadmium Chloride | [Grape Seed Proanthocyanidins co-treated with Cadmium Chloride] affects the expression of KEAP1 protein | 25719599 |
| D019256 | Cadmium Chloride | Grape Seed Proanthocyanidins inhibits the reaction [Cadmium Chloride results in increased expression of KEAP1 protein] | 26462792 |
| D002246 | Carbon Disulfide | Carbon Disulfide results in decreased expression of KEAP1 protein | 27530093 |
| D002248 | Carbon Monoxide | Carbon Monoxide inhibits the reaction [NFE2L2 protein binds to KEAP1 protein] | 18845810 |
| D047188 | Chalcones | Chalcones analog results in decreased expression of KEAP1 protein | 23963778 |
| D002699 | Chlorambucil | Buthionine Sulfoximine inhibits the reaction [[KEAP1 gene mutant form results in increased activity of NFE2L2] which results in decreased susceptibility to Chlorambucil] | 19608619 |
| D002699 | Chlorambucil | [KEAP1 gene mutant form results in increased activity of NFE2L2] which results in decreased susceptibility to Chlorambucil | 19608619 |
| C004656 | chloroacetaldehyde | chloroacetaldehyde results in increased expression of KEAP1 mRNA | 25596134 |
| D020245 | p-Chloromercuribenzoic Acid | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KEAP1 mRNA" | 27188386 |
| D020245 | p-Chloromercuribenzoic Acid | p-Chloromercuribenzoic Acid results in increased expression of KEAP1 mRNA | 26272509 |
| D002794 | Choline | KEAP1 affects the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of CD36 mRNA] | 20350562 |
| D002794 | Choline | KEAP1 affects the susceptibility to [Choline deficiency co-treated with Methionine deficiency] | 20350562 |
| D002794 | Choline | NFE2L2 affects the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of KEAP1 mRNA] | 20350562 |
| C059262 | cidofovir | cidofovir results in increased expression of KEAP1 mRNA | 25596134 |
| C012843 | cinnamic aldehyde | cinnamic aldehyde results in increased expression of KEAP1 protein | 19033392 |
| C012843 | cinnamic aldehyde | cinnamic aldehyde affects the expression of KEAP1 mRNA | 28219650 |
| C028677 | clivorine | clivorine results in increased expression of KEAP1 mRNA | 25881548 |
| D004002 | Clodronic Acid | Clodronic Acid results in increased expression of KEAP1 mRNA | 25596134 |
| D002995 | Clofibric Acid | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of KEAP1 mRNA | 17602206 |
| D003035 | Cobalt | Cobalt binds to KEAP1 protein | 15865434 |
| D003035 | Cobalt | Zinc inhibits the reaction [Cobalt binds to KEAP1 protein] | 15865434 |
| C018021 | cobaltous chloride | cobaltous chloride results in increased expression of KEAP1 mRNA | 24386269 |
| D009249 | NADP | KEAP1 protein affects the abundance of NADP | 21775727 |
| D003300 | Copper | Copper results in increased expression of KEAP1 mRNA | 25461751 |
| C007164 | cumene hydroperoxide | Buthionine Sulfoximine inhibits the reaction [[KEAP1 gene mutant form results in increased activity of NFE2L2] which results in decreased susceptibility to cumene hydroperoxide] | 19608619 |
| C007164 | cumene hydroperoxide | [KEAP1 gene mutant form results in increased activity of NFE2L2] which results in decreased susceptibility to cumene hydroperoxide | 19608619 |
| D003474 | Curcumin | Curcumin results in increased expression of KEAP1 mRNA | 23710286 |
| D003474 | Curcumin | Curcumin results in increased expression of KEAP1 mRNA | 21256849 |
| D003474 | Curcumin | Curcumin analog results in decreased expression of KEAP1 protein | 26991801 |
| D003474 | Curcumin | KEAP1 protein inhibits the reaction [Curcumin results in increased expression of HMOX1 mRNA] | 17535857 |
| C057862 | cyanoginosin LR | cyanoginosin LR binds to KEAP1 protein | 20722399 |
| D016572 | Cyclosporine | Cyclosporine results in increased expression of KEAP1 mRNA | 25596134 |
| D016572 | Cyclosporine | Cyclosporine results in decreased expression of KEAP1 mRNA | 25596134 |
| C014347 | decitabine | [decitabine affects the methylation of KEAP1 promoter] which affects the expression of KEAP1 mRNA | 18555005|1855500 |
| C014347 | decitabine | decitabine results in increased expression of KEAP1 mRNA | 20124447 |
| C050229 | demethoxycurcumin | KEAP1 protein inhibits the reaction [demethoxycurcumin results in increased expression of HMOX1 mRNA] | 17535857 |
| C031710 | dexamethasone 21-methanesulfonate | dexamethasone 21-methanesulfonate affects the metabolism of KEAP1 protein | 18785192 |
| C031710 | dexamethasone 21-methanesulfonate | dexamethasone 21-methanesulfonate binds to KEAP1 protein | 15865434 |
| C031710 | dexamethasone 21-methanesulfonate | Edetic Acid promotes the reaction [dexamethasone 21-methanesulfonate binds to KEAP1 protein] | 15865434 |
| C031710 | dexamethasone 21-methanesulfonate | Egtazic Acid promotes the reaction [dexamethasone 21-methanesulfonate binds to KEAP1 protein] | 15865434 |
| C031710 | dexamethasone 21-methanesulfonate | "N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [dexamethasone 21-methanesulfonate binds to KEAP1 protein]" | 15865434 |
| C042577 | diallyl trisulfide | diallyl trisulfide binds to KEAP1 protein | 24489685 |
| C042577 | diallyl trisulfide | diallyl trisulfide promotes the reaction [KEAP1 mutant form affects the localization of NFE2L2 protein] | 24489685 |
| C042577 | diallyl trisulfide | diallyl trisulfide results in decreased expression of KEAP1 protein | 23453443 |
| D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in decreased expression of KEAP1 mRNA | 17361019 |
| D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in decreased expression of KEAP1 mRNA | 21266533 |
| D002945 | Cisplatin | [Cisplatin co-treated with jinfukang] results in increased expression of KEAP1 mRNA | 27392435 |
| D002945 | Cisplatin | Cisplatin results in increased expression of KEAP1 mRNA | 25596134|2759478 |
| D002945 | Cisplatin | [KEAP1 protein results in decreased stability of NFE2L2 protein] which results in increased susceptibility to Cisplatin | 20530669 |
| D002945 | Cisplatin | KEAP1 protein results in increased susceptibility to Cisplatin | 25841332 |
| D004026 | Dieldrin | Dieldrin results in decreased expression of KEAP1 mRNA | 23041725 |
| D004040 | Dietary Carbohydrates | [Dietary Fats co-treated with Dietary Carbohydrates] results in increased expression of KEAP1 protein | 21289251 |
| D004040 | Dietary Carbohydrates | [resveratrol co-treated with Plant Extracts] inhibits the reaction [[Dietary Fats co-treated with Dietary Carbohydrates] results in increased expression of KEAP1 protein] | 21289251 |
| D004040 | Dietary Carbohydrates | [resveratrol co-treated with Polyphenols] inhibits the reaction [[Dietary Fats co-treated with Dietary Carbohydrates] results in increased expression of KEAP1 protein] | 21289251 |
| D004041 | Dietary Fats | [Dietary Fats co-treated with Dietary Carbohydrates] results in increased expression of KEAP1 protein | 21289251 |
| D004041 | Dietary Fats | [resveratrol co-treated with Plant Extracts] inhibits the reaction [[Dietary Fats co-treated with Dietary Carbohydrates] results in increased expression of KEAP1 protein] | 21289251 |
| D004041 | Dietary Fats | [resveratrol co-treated with Polyphenols] inhibits the reaction [[Dietary Fats co-treated with Dietary Carbohydrates] results in increased expression of KEAP1 protein] | 21289251 |
| D004041 | Dietary Fats | Dietary Fats results in decreased expression of KEAP1 mRNA | 18042831 |
| D004041 | Dietary Fats | Dietary Fats results in increased expression of KEAP1 protein | 23551926 |
| D004041 | Dietary Fats | Fish Oils inhibits the reaction [Dietary Fats results in increased expression of KEAP1 protein] | 23551926 |
| D004041 | Dietary Fats | resveratrol inhibits the reaction [Dietary Fats results in increased expression of KEAP1 protein] | 23551926 |
| C014476 | diethyl maleate | diethyl maleate results in increased expression of KEAP1 protein | 27358234 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of KEAP1 mRNA | 17602206 |
| C039060 | dihydroartemisinin | dihydroartemisinin analog binds to KEAP1 protein | 26340163 |
| C472036 | dihydromyricetin | [dihydromyricetin co-treated with Ethanol] results in decreased expression of KEAP1 protein | 28419832 |
| D004112 | Dimercaprol | Dimercaprol binds to KEAP1 protein | 19808700 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "9,10-Dimethyl-1,2-benzanthracene results in decreased expression of KEAP1 mRNA" | 22485181 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "9,10-Dimethyl-1,2-benzanthracene results in increased expression of KEAP1 mRNA" | 24995432 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "9,10-Dimethyl-1,2-benzanthracene results in increased expression of KEAP1 protein" | 24995432 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of KEAP1 mRNA]" | 24995432 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of KEAP1 protein]" | 24995432 |
| D004137 | Dinitrochlorobenzene | Acetylcysteine inhibits the reaction [Dinitrochlorobenzene results in increased expression of KEAP1 protein] | 19033392 |
| D004137 | Dinitrochlorobenzene | Dinitrochlorobenzene promotes the reaction [KEAP1 protein binds to KEAP1 protein] | 25742418 |
| D004137 | Dinitrochlorobenzene | Dinitrochlorobenzene results in increased expression of KEAP1 protein | 19033392 |
| D004137 | Dinitrochlorobenzene | tetrachlorobenzoquinone promotes the reaction [Dinitrochlorobenzene promotes the reaction [KEAP1 protein binds to KEAP1 protein]] | 25742418 |
| D004137 | Dinitrochlorobenzene | Dinitrochlorobenzene affects the metabolism of KEAP1 protein | 18785192 |
| D004137 | Dinitrochlorobenzene | Dinitrochlorobenzene results in decreased expression of KEAP1 mRNA | 28219650 |
| C019357 | dioscin | dioscin inhibits the reaction [Doxorubicin results in increased expression of KEAP1 protein] | 28082111 |
| D004178 | Diquat | KEAP1 gene mutant form inhibits the reaction [Diquat results in decreased abundance of Glutathione] | 22762311 |
| D004178 | Diquat | [KEAP1 gene mutant form inhibits the reaction [Diquat results in decreased abundance of Glutathione]] which results in increased expression of GCLC mRNA | 22762311 |
| D004178 | Diquat | KEAP1 gene mutant form inhibits the reaction [NFE2L2 gene mutant form results in increased susceptibility to Diquat] | 22762311 |
| D004281 | Docosahexaenoic Acids | Docosahexaenoic Acids inhibits the reaction [KEAP1 protein binds to CUL3 protein] | 25742418 |
| D004317 | Doxorubicin | KEAP1 mRNA results in increased susceptibility to Doxorubicin | 26708503 |
| D004317 | Doxorubicin | KEAP1 protein results in decreased export of and results in increased susceptibility to Doxorubicin | 25841332 |
| D004317 | Doxorubicin | KEAP1 protein results in decreased susceptibility to Doxorubicin | 22684020 |
| D004317 | Doxorubicin | dioscin inhibits the reaction [Doxorubicin results in increased expression of KEAP1 protein] | 28082111 |
| D004317 | Doxorubicin | Doxorubicin results in decreased expression of KEAP1 protein | 24211725 |
| D004317 | Doxorubicin | Doxorubicin results in increased degradation of KEAP1 protein | 24211725 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of KEAP1 protein | 28082111 |
| D004317 | Doxorubicin | KEAP1 protein affects the susceptibility to Doxorubicin | 24211725 |
| D004492 | Edetic Acid | Edetic Acid promotes the reaction [dexamethasone 21-methanesulfonate binds to KEAP1 protein] | 15865434 |
| D004533 | Egtazic Acid | Egtazic Acid promotes the reaction [dexamethasone 21-methanesulfonate binds to KEAP1 protein] | 15865434 |
| D000431 | Ethanol | [dihydromyricetin co-treated with Ethanol] results in decreased expression of KEAP1 protein | 28419832 |
| D005000 | Ethionamide | KEAP1 mRNA inhibits the reaction [Ethionamide results in increased susceptibility to arsenic trioxide] | 26708503 |
| D005047 | Etoposide | KEAP1 mRNA results in increased susceptibility to Etoposide | 26708503 |
| D005047 | Etoposide | KEAP1 protein affects the reaction [Etoposide results in increased expression of CDKN1A protein] | 27982581 |
| D005047 | Etoposide | KEAP1 protein results in decreased susceptibility to Etoposide | 22684020 |
| C034379 | falcarindiol | falcarindiol affects the folding of KEAP1 protein | 20026152 |
| C034379 | falcarindiol | falcarindiol binds to and results in increased alkylation of KEAP1 protein | 20026152 |
| C034379 | falcarindiol | falcarindiol inhibits the reaction [KEAP1 protein results in decreased activity of NFE2L2 protein] | 20026152 |
| C034379 | falcarindiol | falcarindiol results in decreased activity of KEAP1 protein | 20026152 |
| C034379 | falcarindiol | Glutathione inhibits the reaction [falcarindiol binds to and results in increased alkylation of KEAP1 protein] | 20026152 |
| C015881 | farrerol | farrerol results in decreased expression of KEAP1 protein | 26111761 |
| D018120 | Finasteride | Finasteride results in increased expression of KEAP1 mRNA | 24136188 |
| D005395 | Fish Oils | Fish Oils inhibits the reaction [Dietary Fats results in increased expression of KEAP1 protein] | 23551926 |
| D005419 | Flavonoids | Flavonoids results in decreased expression of KEAP1 mRNA | 18035473 |
| D005472 | Fluorouracil | KEAP1 protein affects the susceptibility to Fluorouracil | 18692501 |
| D005485 | Flutamide | Flutamide results in increased expression of KEAP1 mRNA | 24136188 |
| C069837 | fullerene C60 | fullerene C60 results in increased expression of KEAP1 mRNA | 19167457 |
| C419708 | gefitinib | gefitinib results in increased expression of KEAP1 mRNA | 27639429 |
| D005907 | Gliclazide | Gliclazide inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in increased expression of KEAP1 mRNA] | 21439372 |
| D005907 | Gliclazide | Gliclazide inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in increased expression of KEAP1 protein] | 21439372 |
| D005947 | Glucose | [NFE2L2 protein co-treated with KEAP1 protein] affects the abundance of Glucose | 23017736 |
| D005978 | Glutathione | Buthionine Sulfoximine inhibits the reaction [[KEAP1 gene mutant form results in increased activity of NFE2L2] which results in increased abundance of Glutathione] | 19608619 |
| D005978 | Glutathione | [KEAP1 gene mutant form results in increased activity of NFE2L2] which results in increased abundance of Glutathione | 19608619 |
| D005978 | Glutathione | [Plant Extracts results in decreased expression of KEAP1 protein] which results in increased chemical synthesis of Glutathione | 21972102 |
| D005978 | Glutathione | "Glutathione inhibits the reaction [1,2-dihydroxynaphthalene analog results in increased metabolism of KEAP1 protein]" | 25807370 |
| D005978 | Glutathione | "Glutathione inhibits the reaction [2-(pro-1-ynyl)-5-(5,6-dihydroxypenta-1,3-diynyl)thiophene results in increased glutathionylation of KEAP1 protein]" | 20800667 |
| D005978 | Glutathione | KEAP1 gene mutant form inhibits the reaction [Diquat results in decreased abundance of Glutathione] | 22762311 |
| D005978 | Glutathione | [KEAP1 gene mutant form inhibits the reaction [Diquat results in decreased abundance of Glutathione]] which results in increased expression of GCLC mRNA | 22762311 |
| D005978 | Glutathione | KEAP1 gene mutant form results in increased abundance of Glutathione | 26827822 |
| D005978 | Glutathione | Glutathione inhibits the reaction [falcarindiol binds to and results in increased alkylation of KEAP1 protein] | 20026152 |
| C511402 | Grape Seed Proanthocyanidins | [Grape Seed Proanthocyanidins co-treated with Cadmium Chloride] affects the expression of KEAP1 mRNA | 25719599 |
| C511402 | Grape Seed Proanthocyanidins | [Grape Seed Proanthocyanidins co-treated with Cadmium Chloride] affects the expression of KEAP1 protein | 25719599 |
| C511402 | Grape Seed Proanthocyanidins | Grape Seed Proanthocyanidins inhibits the reaction [Cadmium Chloride results in increased expression of KEAP1 protein] | 26462792 |
| D006427 | Hemin | Hemin results in decreased expression of KEAP1 protein | 27777014 |
| C015924 | histidyl-proline diketopiperazine | histidyl-proline diketopiperazine affects the localization of KEAP1 protein | 19735445 |
| C015924 | histidyl-proline diketopiperazine | KEAP1 mRNA affects the susceptibility to histidyl-proline diketopiperazine | 19735445 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide promotes the reaction [KEAP1 protein binds to KEAP1 protein] | 25742418 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in decreased expression of KEAP1 mRNA | 23410634 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide promotes the reaction [4-(2-pyridylazo)resorcinol inhibits the reaction [Zinc binds to KEAP1 protein]] | 15865434 |
| D006894 | Hydroxyestrones | Hydroxyestrones binds to KEAP1 protein | 19952498 |
| C013038 | hydroxyhydroquinone | hydroxyhydroquinone results in increased expression of KEAP1 mRNA | 17572062 |
| D006997 | Hypochlorous Acid | Hypochlorous Acid results in increased expression of KEAP1 mRNA | 17980396 |
| D007069 | Ifosfamide | Ifosfamide results in increased expression of KEAP1 mRNA | 25596134 |
| D007213 | Indomethacin | Acetylcysteine inhibits the reaction [Indomethacin inhibits the reaction [KEAP1 protein binds to NFE2L2 protein]] | 11909699 |
| D007213 | Indomethacin | Indomethacin inhibits the reaction [KEAP1 protein binds to NFE2L2 protein] | 11909699 |
| D007213 | Indomethacin | KEAP1 protein inhibits the reaction [Indomethacin results in increased expression of GCLC mRNA] | 11909699 |
| D007460 | Iodoacetamide | Iodoacetamide inhibits the reaction [sulforafan results in increased metabolism of KEAP1 protein] | 21391649 |
| D007460 | Iodoacetamide | Iodoacetamide results in increased expression of KEAP1 protein | 27358234 |
| D007460 | Iodoacetamide | Iodoacetamide affects the metabolism of KEAP1 protein | 18785192 |
| C544151 | jinfukang | [Cisplatin co-treated with jinfukang] results in increased expression of KEAP1 mRNA | 27392435 |
| C561695 | (+)-JQ1 compound | (+)-JQ1 compound promotes the reaction [oltipraz results in increased expression of KEAP1 mRNA] | 27233051 |
| C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in increased expression of KEAP1 mRNA | 27233051 |
| C561695 | (+)-JQ1 compound | oltipraz promotes the reaction [(+)-JQ1 compound results in increased expression of KEAP1 mRNA] | 27233051 |
| C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in decreased expression of KEAP1 mRNA | 23430699|2476305 |
| C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in decreased expression of KEAP1 protein | 24733848 |
| C410337 | K 7174 | K 7174 results in increased expression of KEAP1 mRNA | 24086573 |
| D048628 | Ketolides | Ketolides analog results in decreased expression of KEAP1 mRNA | 24967691 |
| D064747 | Lansoprazole | Lansoprazole results in increased oxidation of KEAP1 protein | 19628634 |
| C045463 | leflunomide | leflunomide results in increased expression of KEAP1 mRNA | 24136188 |
| C038018 | lilial | lilial results in increased expression of KEAP1 protein | 19033392 |
| C002385 | linsidomine | KEAP1 mRNA affects the susceptibility to linsidomine | 16092930 |
| C482199 | lipopolysaccharide, E coli O55-B5 | "KEAP1 gene mutant form promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL6 mRNA]" | 23906629 |
| C482199 | lipopolysaccharide, E coli O55-B5 | "KEAP1 gene mutant form promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NQO1 mRNA]" | 23906629 |
| C482199 | lipopolysaccharide, E coli O55-B5 | "Thiophenes inhibits the reaction [KEAP1 gene mutant form promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL6 mRNA]]" | 23906629 |
| C482199 | lipopolysaccharide, E coli O55-B5 | "IKBKB gene mutant form inhibits the reaction [KEAP1 gene mutant form promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL6 mRNA]]" | 23906629 |
| C482199 | lipopolysaccharide, E coli O55-B5 | "KEAP1 gene mutant form promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CD36 mRNA]" | 23906629 |
| C482199 | lipopolysaccharide, E coli O55-B5 | "KEAP1 gene mutant form promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of HMOX1 mRNA]" | 23906629 |
| C482199 | lipopolysaccharide, E coli O55-B5 | "KEAP1 gene mutant form promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL1B mRNA]" | 23906629 |
| C482199 | lipopolysaccharide, E coli O55-B5 | "KEAP1 gene mutant form promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL6 mRNA]" | 23906629 |
| C482199 | lipopolysaccharide, E coli O55-B5 | "KEAP1 gene mutant form promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NQO1 mRNA]" | 23906629 |
| C482199 | lipopolysaccharide, E coli O55-B5 | "KEAP1 gene mutant form promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of TNF mRNA]" | 23906629 |
| C482199 | lipopolysaccharide, E coli O55-B5 | "KEAP1 gene mutant form promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of IL6 protein]" | 23906629 |
| C482199 | lipopolysaccharide, E coli O55-B5 | "KEAP1 protein affects the reaction [lipopolysaccharide, E coli O55-B5 affects the expression of CHUK protein]" | 23906629 |
| C482199 | lipopolysaccharide, E coli O55-B5 | "KEAP1 protein affects the reaction [lipopolysaccharide, E coli O55-B5 affects the expression of IKBKB protein]" | 23906629 |
| C482199 | lipopolysaccharide, E coli O55-B5 | "KEAP1 protein affects the reaction [lipopolysaccharide, E coli O55-B5 affects the phosphorylation of and affects the expression of RELA protein]" | 23906629 |
| C482199 | lipopolysaccharide, E coli O55-B5 | "lipopolysaccharide, E coli O55-B5 promotes the reaction [KEAP1 gene mutant form results in increased expression of NFE2L2 protein]" | 23906629 |
| C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "[Plant Preparations co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in decreased expression of KEAP1 protein" | 24675710 |
| D008294 | Malathion | KEAP1 protein results in increased susceptibility to Malathion | 21896655 |
| C025340 | manganese chloride | manganese chloride affects the expression of KEAP1 protein | 25288107 |
| C025340 | manganese chloride | Melatonin affects the reaction [manganese chloride affects the expression of KEAP1 protein] | 25288107 |
| D008550 | Melatonin | Melatonin affects the reaction [manganese chloride affects the expression of KEAP1 protein] | 25288107 |
| D008550 | Melatonin | Melatonin results in decreased expression of KEAP1 protein | 25288107 |
| C042720 | mercuric bromide | mercuric bromide results in increased expression of KEAP1 mRNA | 26272509 |
| C042720 | mercuric bromide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KEAP1 mRNA" | 27188386 |
| D008687 | Metformin | Metformin results in decreased expression of KEAP1 mRNA | 25596134 |
| D008715 | Methionine | KEAP1 affects the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of CD36 mRNA] | 20350562 |
| D008715 | Methionine | KEAP1 affects the susceptibility to [Choline deficiency co-treated with Methionine deficiency] | 20350562 |
| D008715 | Methionine | NFE2L2 affects the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of KEAP1 mRNA] | 20350562 |
| C445068 | methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate | "methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate results in increased expression of KEAP1 protein" | 27358234 |
| C445068 | methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate | "methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate inhibits the reaction [aristolochic acid I results in increased expression of KEAP1 protein]" | 24530882 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of KEAP1 mRNA | 23712962 |
| D008767 | Methylmercury Compounds | Methylmercury Compounds inhibits the reaction [KEAP1 gene mutant form results in increased expression of NFE2L2 protein] | 26827822 |
| D018817 | N-Methyl-3,4-methylenedioxyamphetamine | "N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of KEAP1 mRNA" | 26251327 |
| D018817 | N-Methyl-3,4-methylenedioxyamphetamine | "N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of KEAP1 promoter" | 26251327 |
| C517880 | monascin | monascin inhibits the reaction [S100B protein results in increased expression of KEAP1 protein] | 23331247 |
| C406082 | monomethylarsonous acid | monomethylarsonous acid inhibits the reaction [KEAP1 protein mutant form results in increased ubiquitination of NFE2L2 protein] | 18417180 |
| C406082 | monomethylarsonous acid | monomethylarsonous acid inhibits the reaction [KEAP1 protein results in increased ubiquitination of NFE2L2 protein] | 18417180 |
| C406082 | monomethylarsonous acid | monomethylarsonous acid promotes the reaction [KEAP1 protein binds to CUL3 protein] | 18417180 |
| C406082 | monomethylarsonous acid | monomethylarsonous acid promotes the reaction [KEAP1 protein binds to NFE2L2 protein] | 18417180 |
| C028473 | N-acetyl-4-benzoquinoneimine | KEAP1 protein inhibits the reaction [NQO1 protein results in increased metabolism of N-acetyl-4-benzoquinoneimine] | 19246624 |
| C028473 | N-acetyl-4-benzoquinoneimine | N-acetyl-4-benzoquinoneimine affects the metabolism of KEAP1 protein | 18785192 |
| C051752 | nefazodone | nefazodone results in increased expression of KEAP1 mRNA | 24136188 |
| D009532 | Nickel | Nickel results in increased expression of KEAP1 protein | 19033392 |
| C028007 | nickel monoxide | nickel monoxide results in increased expression of KEAP1 mRNA | 19167457 |
| C044387 | N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine | "N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [dexamethasone 21-methanesulfonate binds to KEAP1 protein]" | 15865434 |
| C025256 | nonylphenol | [nonylphenol co-treated with bisphenol A] results in increased expression of KEAP1 mRNA | 23606268 |
| C025256 | nonylphenol | nonylphenol results in increased expression of KEAP1 mRNA | 23606268 |
| D016627 | Oxidopamine | KEAP1 mRNA affects the susceptibility to Oxidopamine | 16092930 |
| D016627 | Oxidopamine | Oxidopamine promotes the reaction [NFE2L2 protein binds to KEAP1 protein] | 23274087 |
| C026209 | oltipraz | (+)-JQ1 compound promotes the reaction [oltipraz results in increased expression of KEAP1 mRNA] | 27233051 |
| C026209 | oltipraz | oltipraz promotes the reaction [(+)-JQ1 compound results in increased expression of KEAP1 mRNA] | 27233051 |
| C026209 | oltipraz | oltipraz results in increased expression of KEAP1 mRNA | 27233051 |
| C029341 | oxophenylarsine | oxophenylarsine binds to KEAP1 protein | 19786557|1980870 |
| D010100 | Oxygen | Oxygen deficiency results in decreased expression of KEAP1 mRNA | 25596134 |
| D017239 | Paclitaxel | [KEAP1 protein results in decreased stability of NFE2L2 protein] which results in increased susceptibility to Paclitaxel | 20530669 |
| D000073878 | Palm Oil | Palm Oil results in decreased expression of KEAP1 mRNA | 18042831 |
| D010416 | Pentachlorophenol | Pentachlorophenol results in increased expression of KEAP1 mRNA | 23892564 |
| C076994 | perfluorooctane sulfonic acid | perfluorooctane sulfonic acid results in decreased expression of KEAP1 mRNA | 20621739 |
| C033342 | perillaldehyde | KEAP1 protein inhibits the reaction [perillaldehyde results in increased expression of TXN mRNA] | 19123792 |
| D010590 | Phalloidine | KEAP1 gene mutant form inhibits the reaction [Phalloidine results in increased expression of CXCL1 mRNA] | 25280775 |
| D010590 | Phalloidine | KEAP1 gene mutant form inhibits the reaction [Phalloidine results in increased expression of CXCL2 mRNA] | 25280775 |
| D010590 | Phalloidine | KEAP1 gene mutant form inhibits the reaction [Phalloidine results in increased expression of DDIT3 mRNA] | 25280775 |
| D010590 | Phalloidine | KEAP1 gene mutant form inhibits the reaction [Phalloidine results in increased expression of GADD45A mRNA] | 25280775 |
| D010590 | Phalloidine | KEAP1 gene mutant form inhibits the reaction [Phalloidine results in increased expression of HMOX1 mRNA] | 25280775 |
| D010590 | Phalloidine | KEAP1 gene mutant form results in decreased susceptibility to Phalloidine | 25280775 |
| D010590 | Phalloidine | [KEAP1 gene mutant form results in decreased susceptibility to Phalloidine] which results in decreased expression of CXCL1 mRNA | 25280775 |
| D010590 | Phalloidine | [KEAP1 gene mutant form results in decreased susceptibility to Phalloidine] which results in decreased expression of CXCL2 mRNA | 25280775 |
| D010590 | Phalloidine | [KEAP1 gene mutant form results in decreased susceptibility to Phalloidine] which results in decreased expression of DDIT3 mRNA | 25280775 |
| D010590 | Phalloidine | [KEAP1 gene mutant form results in decreased susceptibility to Phalloidine] which results in decreased expression of GADD45A mRNA | 25280775 |
| D010590 | Phalloidine | [KEAP1 gene mutant form results in decreased susceptibility to Phalloidine] which results in decreased expression of HMOX1 mRNA | 25280775 |
| D010590 | Phalloidine | [KEAP1 gene mutant form results in decreased susceptibility to Phalloidine] which results in increased expression of MT1 mRNA | 25280775 |
| D010590 | Phalloidine | [KEAP1 gene mutant form results in decreased susceptibility to Phalloidine] which results in increased expression of SLCO1B2 mRNA | 25280775 |
| D010590 | Phalloidine | Phalloidine promotes the reaction [KEAP1 gene mutant form results in increased expression of NFE2L2 mRNA] | 25280775 |
| D010590 | Phalloidine | Phalloidine promotes the reaction [KEAP1 gene mutant form results in increased expression of NQO1 mRNA] | 25280775 |
| D010634 | Phenobarbital | KEAP1 protein affects the reaction [Phenobarbital results in increased expression of CYP6A2 mRNA] | 21896655 |
| D010634 | Phenobarbital | KEAP1 protein affects the reaction [Phenobarbital results in increased expression of CYP6A8 mRNA] | 21896655 |
| D010634 | Phenobarbital | KEAP1 protein affects the reaction [Phenobarbital results in increased expression of GSTD2 mRNA] | 21896655 |
| D010634 | Phenobarbital | KEAP1 protein affects the reaction [Phenobarbital results in increased expression of GSTD7 mRNA] | 21896655 |
| D010634 | Phenobarbital | KEAP1 protein affects the reaction [Phenobarbital results in increased expression of JHEH1 mRNA] | 21896655 |
| D010634 | Phenobarbital | Phenobarbital results in increased expression of KEAP1 mRNA | 21896655 |
| D010634 | Phenobarbital | KEAP1 protein affects the reaction [Phenobarbital results in increased expression of CYP2A5 mRNA] | 22859313 |
| D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KEAP1 mRNA" | 27188386 |
| D010662 | Phenylmercuric Acetate | Phenylmercuric Acetate results in increased expression of KEAP1 mRNA | 26272509 |
| D010695 | Phlorhizin | Phlorhizin results in increased expression of KEAP1 mRNA | 22538082 |
| C006253 | pirinixic acid | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of KEAP1 mRNA | 19710929 |
| D010936 | Plant Extracts | Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased expression of KEAP1 protein] | 27050144 |
| D010936 | Plant Extracts | Plant Extracts results in decreased expression of KEAP1 protein | 21972102 |
| D010936 | Plant Extracts | [Plant Extracts results in decreased expression of KEAP1 protein] which results in increased chemical synthesis of Glutathione | 21972102 |
| D010936 | Plant Extracts | [resveratrol co-treated with Plant Extracts] inhibits the reaction [[Dietary Fats co-treated with Dietary Carbohydrates] results in increased expression of KEAP1 protein] | 21289251 |
| D028321 | Plant Preparations | "[Plant Preparations co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in decreased expression of KEAP1 protein" | 24675710 |
| D028321 | Plant Preparations | Plant Preparations results in decreased expression of KEAP1 mRNA | 24973489 |
| D011078 | Polychlorinated Biphenyls | Polychlorinated Biphenyls analog results in increased expression of KEAP1 protein | 24361488 |
| D059808 | Polyphenols | [resveratrol co-treated with Polyphenols] inhibits the reaction [[Dietary Fats co-treated with Dietary Carbohydrates] results in increased expression of KEAP1 protein] | 21289251 |
| D011192 | Potassium Dichromate | Potassium Dichromate affects the localization of and results in decreased ubiquitination of KEAP1 protein | 17420218 |
| D011192 | Potassium Dichromate | Potassium Dichromate inhibits the reaction [NFE2L2 protein binds to KEAP1 protein] | 17420218 |
| C107773 | pterostilbene | pterostilbene inhibits the reaction [NFE2L2 protein binds to KEAP1 protein] | 26700463 |
| D011794 | Quercetin | Quercetin inhibits the reaction [tert-Butylhydroperoxide results in increased expression of KEAP1 protein] | 27050144 |
| D011794 | Quercetin | Quercetin results in increased metabolism of and results in increased degradation of and results in decreased expression of KEAP1 protein | 17462537 |
| D011794 | Quercetin | Quercetin results in increased expression of KEAP1 mRNA | 23295412 |
| D011794 | Quercetin | Quercetin results in decreased expression of KEAP1 protein | 25339115 |
| C012526 | quercitrin | quercitrin results in increased expression of KEAP1 mRNA | 25193878 |
| C502851 | quinocetone | quinocetone results in decreased expression of KEAP1 protein | 27046791 |
| D017382 | Reactive Oxygen Species | Reactive Oxygen Species results in increased expression of KEAP1 mRNA | 25800948 |
| C059514 | resveratrol | [resveratrol co-treated with Plant Extracts] inhibits the reaction [[Dietary Fats co-treated with Dietary Carbohydrates] results in increased expression of KEAP1 protein] | 21289251 |
| C059514 | resveratrol | [resveratrol co-treated with Polyphenols] inhibits the reaction [[Dietary Fats co-treated with Dietary Carbohydrates] results in increased expression of KEAP1 protein] | 21289251 |
| C059514 | resveratrol | resveratrol inhibits the reaction [NFE2L2 protein binds to KEAP1 protein] | 16948474 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Dietary Fats results in increased expression of KEAP1 protein] | 23551926 |
| C059514 | resveratrol | resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in increased expression of KEAP1 mRNA] | 21439372 |
| C059514 | resveratrol | resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in increased expression of KEAP1 protein] | 21439372 |
| C059514 | resveratrol | KEAP1 protein inhibits the reaction [resveratrol results in decreased activity of TNF protein] | 20418481 |
| C059514 | resveratrol | KEAP1 protein inhibits the reaction [resveratrol results in increased expression of GCLC mRNA] | 20418481 |
| C059514 | resveratrol | KEAP1 protein inhibits the reaction [resveratrol results in increased expression of HMOX1 mRNA] | 20418481 |
| C059514 | resveratrol | KEAP1 protein inhibits the reaction [resveratrol results in increased expression of NQO1 mRNA] | 20418481 |
| C059514 | resveratrol | [KEAP1 protein results in decreased activity of NFE2L2 protein] which results in decreased susceptibility to resveratrol | 20418481 |
| C059514 | resveratrol | KEAP1 protein results in decreased susceptibility to resveratrol | 20418481 |
| C089730 | rosiglitazone | KEAP1 protein promotes the reaction [rosiglitazone results in increased susceptibility to arsenic trioxide] | 22684020 |
| C089730 | rosiglitazone | rosiglitazone results in increased expression of KEAP1 mRNA | 25596134 |
| C089730 | rosiglitazone | rosiglitazone results in increased expression of KEAP1 mRNA | 25596134 |
| D012402 | Rotenone | KEAP1 gene mutant form results in decreased susceptibility to Rotenone | 19167360 |
| D012402 | Rotenone | Rotenone results in decreased expression of KEAP1 mRNA | 23186747 |
| D012402 | Rotenone | [safranal co-treated with Rotenone] affects the expression of KEAP1 | 28145852 |
| C513635 | S-2-pentyl-4-pentynoic hydroxamic acid | S-2-pentyl-4-pentynoic hydroxamic acid results in decreased expression of KEAP1 mRNA | 21427059 |
| C087963 | safranal | [safranal co-treated with Rotenone] affects the expression of KEAP1 | 28145852 |
| D012643 | Selenium | Selenium results in increased expression of KEAP1 mRNA | 19244175 |
| C040115 | shogaol | shogaol metabolite results in decreased expression of KEAP1 protein | 25148906 |
| C040115 | shogaol | shogaol results in decreased expression of KEAP1 protein | 25148906 |
| C040115 | shogaol | shogaol results in increased alkylation of KEAP1 protein | 25148906 |
| C040115 | shogaol | KEAP1 protein affects the reaction [shogaol analog results in increased expression of HMOX1 protein] | 23899529 |
| C040115 | shogaol | KEAP1 protein affects the reaction [shogaol analog results in increased expression of NFE2L2 protein] | 23899529 |
| C040115 | shogaol | KEAP1 protein affects the reaction [shogaol analog results in increased expression of NQO1 protein] | 23899529 |
| C440975 | silybin | silybin inhibits the reaction [sodium arsenite results in increased expression of KEAP1] | 24062023 |
| D012838 | Silymarin | Silymarin inhibits the reaction [S100B protein results in increased expression of KEAP1 protein] | 23331247 |
| C017947 | sodium arsenite | KEAP1 protein promotes the reaction [sodium arsenite results in increased expression of and results in increased activity of NFE2L2 protein] | 23589329 |
| C017947 | sodium arsenite | sodium arsenite affects the localization of KEAP1 protein | 23589329 |
| C017947 | sodium arsenite | sodium arsenite inhibits the reaction [KEAP1 protein mutant form results in increased ubiquitination of NFE2L2 protein] | 18417180 |
| C017947 | sodium arsenite | sodium arsenite inhibits the reaction [KEAP1 protein results in increased ubiquitination of NFE2L2 protein] | 18417180 |
| C017947 | sodium arsenite | sodium arsenite promotes the reaction [KEAP1 protein binds to CUL3 protein] | 18417180 |
| C017947 | sodium arsenite | sodium arsenite promotes the reaction [KEAP1 protein binds to NFE2L2 protein] | 18417180 |
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of KEAP1 protein | 28229933 |
| C017947 | sodium arsenite | sulforafan inhibits the reaction [sodium arsenite affects the localization of KEAP1 protein] | 23589329 |
| C017947 | sodium arsenite | sodium arsenite inhibits the reaction [[CUL3 protein binds to KEAP1 protein] which binds to and results in increased ubiquitination of NFE2L2 protein] | 16785233 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of KEAP1 mRNA | 26371860 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of KEAP1 protein | 26371860 |
| C017947 | sodium arsenite | silybin inhibits the reaction [sodium arsenite results in increased expression of KEAP1] | 24062023 |
| C017947 | sodium arsenite | sodium arsenite affects the expression of KEAP1 mRNA | 25625412 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of KEAP1 | 24062023 |
| C016104 | sodium bichromate | sodium bichromate results in decreased expression of KEAP1 mRNA | 22155349 |
| C017719 | solanesol | solanesol inhibits the reaction [KEAP1 protein binds to CUL3 protein binds to RBX1 protein] | 25645596 |
| C017719 | solanesol | solanesol inhibits the reaction [KEAP1 protein binds to NFE2L2 protein] | 25645596 |
| D013311 | Streptozocin | Gliclazide inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in increased expression of KEAP1 mRNA] | 21439372 |
| D013311 | Streptozocin | Gliclazide inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in increased expression of KEAP1 protein] | 21439372 |
| D013311 | Streptozocin | resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in increased expression of KEAP1 mRNA] | 21439372 |
| D013311 | Streptozocin | resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in increased expression of KEAP1 protein] | 21439372 |
| D013311 | Streptozocin | [Streptozocin co-treated with Niacinamide] results in increased expression of KEAP1 mRNA | 21439372 |
| D013311 | Streptozocin | [Streptozocin co-treated with Niacinamide] results in increased expression of KEAP1 protein | 21439372 |
| D013448 | Sulfobromophthalein | KEAP1 protein results in decreased glutathionylation of Sulfobromophthalein | 19246623 |
| D013448 | Sulfobromophthalein | KEAP1 protein results in decreased transport of Sulfobromophthalein | 19246623 |
| C016766 | sulforafan | Iodoacetamide inhibits the reaction [sulforafan results in increased metabolism of KEAP1 protein] | 21391649 |
| C016766 | sulforafan | KEAP1 protein mutant form inhibits the reaction [sulforafan results in increased expression of and results in increased activity of NFE2L2 protein] | 23589329 |
| C016766 | sulforafan | KEAP1 protein mutant form results in decreased susceptibility to sulforafan | 23589329 |
| C016766 | sulforafan | KEAP1 protein promotes the reaction [sulforafan results in increased expression of and results in increased activity of NFE2L2 protein] | 23589329 |
| C016766 | sulforafan | KEAP1 protein results in increased susceptibility to sulforafan | 22558124 |
| C016766 | sulforafan | sulforafan inhibits the reaction [KEAP1 protein binds to CUL3 protein] | 18417180 |
| C016766 | sulforafan | sulforafan inhibits the reaction [sodium arsenite affects the localization of KEAP1 protein] | 23589329 |
| C016766 | sulforafan | sulforafan promotes the reaction [KEAP1 protein binds to NFE2L2 protein] | 18417180 |
| C016766 | sulforafan | sulforafan promotes the reaction [NFE2L2 protein binds to KEAP1 protein] | 22558124 |
| C016766 | sulforafan | sulforafan results in increased expression of KEAP1 protein | 19033392 |
| C016766 | sulforafan | sulforafan results in increased metabolism of KEAP1 protein | 21391649 |
| C016766 | sulforafan | KEAP1 protein results in increased susceptibility to sulforafan | 22558124 |
| C016766 | sulforafan | sulforafan promotes the reaction [4-(2-pyridylazo)resorcinol inhibits the reaction [Zinc binds to KEAP1 protein]] | 15865434 |
| C016766 | sulforafan | sulforafan promotes the reaction [NFE2L2 protein binds to KEAP1 protein] | 22558124 |
| C016766 | sulforafan | sulforafan inhibits the reaction [KEAP1 protein results in increased ubiquitination of NFE2L2 protein] | 18417180 |
| D013467 | Sulindac | Sulindac results in decreased expression of KEAP1 mRNA | 24136188 |
| C473643 | sulphoraphene | sulphoraphene results in increased expression of KEAP1 mRNA | 29247643 |
| C059006 | tangeretin | "tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of KEAP1 mRNA]" | 24995432 |
| C059006 | tangeretin | "tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of KEAP1 protein]" | 24995432 |
| C531972 | TBE 31 | TBE 31 binds to KEAP1 protein | 21361338 |
| C000591600 | tetrachlorobenzoquinone | tetrachlorobenzoquinone promotes the reaction [Dinitrochlorobenzene promotes the reaction [KEAP1 protein binds to KEAP1 protein]] | 25742418 |
| C000591600 | tetrachlorobenzoquinone | tetrachlorobenzoquinone promotes the reaction [KEAP1 protein binds to KEAP1 protein] | 25742418 |
| C000591600 | tetrachlorobenzoquinone | tetrachlorobenzoquinone results in increased ubiquitination of KEAP1 protein | 25742418 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of KEAP1 mRNA | 21570461 |
| D019284 | Thapsigargin | Thapsigargin results in increased expression of KEAP1 protein | 27358234 |
| D008063 | Thioctic Acid | Thioctic Acid results in increased expression of KEAP1 protein | 19033392 |
| D013876 | Thiophenes | "Thiophenes inhibits the reaction [KEAP1 gene mutant form promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL6 mRNA]]" | 23906629 |
| D014199 | Trehalose | Trehalose inhibits the reaction [cadmium acetate results in decreased expression of KEAP1 protein] | 29140578 |
| D014212 | Tretinoin | [Tretinoin co-treated with arsenic trioxide] results in increased expression of KEAP1 mRNA | 15894607 |
| C012589 | trichostatin A | trichostatin A affects the expression of KEAP1 mRNA | 28542535 |
| C012589 | trichostatin A | trichostatin A results in increased expression of KEAP1 mRNA | 15901671 |
| C050414 | tripterine | tripterine inhibits the reaction [Bleomycin results in decreased expression of KEAP1 protein] | 26768587 |
| C057693 | troglitazone | KEAP1 protein promotes the reaction [troglitazone results in increased susceptibility to arsenic trioxide] | 22684020 |
| C406224 | valdecoxib | valdecoxib results in increased expression of KEAP1 mRNA | 24136188 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of KEAP1 mRNA | 25979313 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of KEAP1 mRNA | 22083351|2915479 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of KEAP1 mRNA | 21427059 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of KEAP1 mRNA | 15901671 |
| C066075 | vanadium pentoxide | vanadium pentoxide results in decreased expression of KEAP1 mRNA | 17459161 |
| D009536 | Niacinamide | Gliclazide inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in increased expression of KEAP1 mRNA] | 21439372 |
| D009536 | Niacinamide | Gliclazide inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in increased expression of KEAP1 protein] | 21439372 |
| D009536 | Niacinamide | resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in increased expression of KEAP1 mRNA] | 21439372 |
| D009536 | Niacinamide | resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in increased expression of KEAP1 protein] | 21439372 |
| D009536 | Niacinamide | [Streptozocin co-treated with Niacinamide] results in increased expression of KEAP1 mRNA | 21439372 |
| D009536 | Niacinamide | [Streptozocin co-treated with Niacinamide] results in increased expression of KEAP1 protein | 21439372 |
| D024483 | Vitamin K 3 | [KEAP1 gene mutant form results in increased activity of NFE2L2] which results in decreased susceptibility to Vitamin K 3 | 19608619 |
| D024483 | Vitamin K 3 | Vitamin K 3 results in decreased expression of KEAP1 mRNA | 23410634 |
| D015032 | Zinc | 4-(2-pyridylazo)resorcinol inhibits the reaction [Zinc binds to KEAP1 protein] | 15865434 |
| D015032 | Zinc | "4,4'-dipyridyl disulfide promotes the reaction [4-(2-pyridylazo)resorcinol inhibits the reaction [Zinc binds to KEAP1 protein]]" | 15865434 |
| D015032 | Zinc | Hydrogen Peroxide promotes the reaction [4-(2-pyridylazo)resorcinol inhibits the reaction [Zinc binds to KEAP1 protein]] | 15865434 |
| D015032 | Zinc | sulforafan promotes the reaction [4-(2-pyridylazo)resorcinol inhibits the reaction [Zinc binds to KEAP1 protein]] | 15865434 |
| D015032 | Zinc | Zinc binds to KEAP1 protein | 15865434 |
| D015032 | Zinc | Zinc inhibits the reaction [Cobalt binds to KEAP1 protein] | 15865434 |